| scholarly article | Q13442814 |
| P50 | author | Maria Demestre | Q84919665 |
| P2093 | author name string | Seung U Kim | |
| Jens Fiehler | |||
| Jan Sedlacik | |||
| Manfred Westphal | |||
| Nils Ole Schmidt | |||
| Matthias Reitz | |||
| Hildegard Meissner | |||
| P2860 | cites work | Neural stem cells and the origin of gliomas | Q28268847 |
| Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 | ||
| Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia | Q33322707 | ||
| Intranasal delivery of cells to the brain. | Q34016739 | ||
| High-resolution BOLD venographic imaging: a window into brain function | Q34105376 | ||
| Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology | Q34738708 | ||
| Strategies for the augmentation of grafted dopamine neuron survival | Q35109477 | ||
| Combining polymeric devices and stem cells for the treatment of neurological disorders: a promising therapeutic approach. | Q36048041 | ||
| Gene therapy: can neural stem cells deliver? | Q36350210 | ||
| Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia | Q36797965 | ||
| Stem and progenitor cell-mediated tumor selective gene therapy | Q37120161 | ||
| Intranasal delivery to the central nervous system: mechanisms and experimental considerations | Q37624592 | ||
| Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a Rosetta stone | Q37879267 | ||
| Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. | Q38922636 | ||
| A 3-dimensional extracellular matrix as a delivery system for the transplantation of glioma-targeting neural stem/progenitor cells | Q39739254 | ||
| Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche | Q39873265 | ||
| Production and characterization of immortal human neural stem cell line with multipotent differentiation property | Q39998097 | ||
| Disparate host response and donor survival after the transplantation of mesenchymal or neuroectodermal cells to the intact rodent brain | Q40142380 | ||
| Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. | Q40394957 | ||
| Volume reconstruction techniques improve the correlation between histological and in vivo tumor volume measurements in mouse models of human gliomas. | Q40486760 | ||
| Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias | Q46634561 | ||
| Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage. | Q48122882 | ||
| Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia | Q48460765 | ||
| Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain | Q48590310 | ||
| Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. | Q48789795 | ||
| Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. | Q50494024 | ||
| Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. | Q50527409 | ||
| Clinical potential of intravenous neural stem cell delivery for treatment of neuroinflammatory disease in mice? | Q50534121 | ||
| Comparative study of methods for administering neural stem/progenitor cells to treat spinal cord injury in mice | Q82335333 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 866-873 | |
| P577 | publication date | 2012-11-27 | |
| P1433 | published in | Stem Cells Translational Medicine | Q26842216 |
| P1476 | title | Intranasal delivery of neural stem/progenitor cells: a noninvasive passage to target intracerebral glioma | |
| P478 | volume | 1 |
| Q34396290 | A systematic review of inhaled intranasal therapy for central nervous system neoplasms: an emerging therapeutic option |
| Q64880151 | Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke: Clinical Outcomes from a Phase I Safety Study. |
| Q27025754 | Cell based therapies for ischemic stroke: from basic science to bedside |
| Q38226664 | Cells as delivery vehicles for cancer therapeutics |
| Q64276142 | Deciduous DPSCs Ameliorate MPTP-Mediated Neurotoxicity, Sensorimotor Coordination and Olfactory Function in Parkinsonian Mice |
| Q37029367 | Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma? |
| Q55255305 | Enhanced Homing Technique of Mesenchymal Stem Cells Using Iron Oxide Nanoparticles by Magnetic Attraction in Olfactory-Injured Mouse Models. |
| Q33844966 | Enhancing effect of borneol and muscone on geniposide transport across the human nasal epithelial cell monolayer |
| Q34383339 | Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM? |
| Q40060078 | Gene Delivery in Neuro-Oncology |
| Q42368133 | Human mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal? |
| Q90641955 | Imaging of intranasal drug delivery to the brain |
| Q52331546 | In Vivo Photoacoustic Imaging of Brain Injury and Rehabilitation by High-Efficient Near-Infrared Dye Labeled Mesenchymal Stem Cells with Enhanced Brain Barrier Permeability. |
| Q48766381 | Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model |
| Q37274612 | Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma |
| Q42228954 | Intranasal administration of plasmid DNA nanoparticles yields successful transfection and expression of a reporter protein in rat brain. |
| Q38303586 | Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease |
| Q38648551 | Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors |
| Q48117495 | Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies. |
| Q38342080 | Intranasal delivery of stem cells as therapy for central nervous system disease |
| Q34095987 | Intravenous transplantation of bone marrow mesenchymal stem cells promotes neural regeneration after traumatic brain injury |
| Q47228668 | Migratory potential of transplanted glial progenitors as critical factor for successful translation of glia replacement therapy: The gap between mice and men. |
| Q64070071 | Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma |
| Q38245163 | Stem cell-based therapies for cancer treatment: separating hope from hype |
| Q38855638 | Stem cell-based therapies for tumors in the brain: are we there yet? |
| Q37420576 | Strategies in gene therapy for glioblastoma. |
| Q26850467 | Sui generis: gene therapy and delivery systems for the treatment of glioblastoma |
| Q55610792 | The Route by Which Intranasally Delivered Stem Cells Enter the Central Nervous System. |
| Q38236698 | The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview |
Search more.